What is your preferred first-line regimen for metastatic head and neck cancer?

5-FU/platinum/cetuximab is probably the textbook answer given that the study evaluating it, EXTREME represents the only positive phase III study ever in 1st line palliative head/neck treatment. However, in my practice, I reject it for human reasons. Simply put, the study was well named - the toxicit...